Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Arrese

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Revista Medica De Chile|February 7, 2001
[Identification of molecular defects in liver diseases. Recent advances]M Arrese
Revista Medica De Chile|April 1, 1993
[Ursodeoxycholic acid in the treatment of cholestatic liver diseases]M Arrese, L Accatino
Journal of Virology|June 1, 1996
Serine 3 is critical for phosphorylation at the N-terminal end of the nucleoprotein of influenza virus A/Victoria/3/75M Arrese, A Portela
Clinical Pharmacology and Therapeutics|March 5, 2010
Nuclear receptors, inflammation, and liver disease: insights for cholestatic and fatty liver diseasesM Arrese, S J Karpen
Revista Medica De Chile|February 11, 2000
[Molecular biology and medicine: basic concepts]S Zanlungo, A Rigotti, M Arrese
Revista Medica De Chile|February 7, 2001
[Molecular medicine: present and future]S Zanlungo, M Arrese, A Rigotti
Revista Medica De Chile|March 1, 1991
[Eosinophilic pneumonia causing severe respiratory insufficiency. Clinical case]M Arrese, J M Castellón, G Contreras
Pediatric Research|August 14, 1998
Hepatobiliary transport: molecular mechanisms of development and cholestasisM Arrese, M Ananthananarayanan, F J Suchy
Journal of Hepatology|March 1, 1997
Adaptive regulation of hepatic bile salt transport: role of bile salt hydrophobicity and microtubule-dependent vesicular pathwayM Arrese, M Pizarro, N Solís, et al.
Biochemical Pharmacology|October 12, 1995
Enhanced biliary excretion of canalicular membrane enzymes in ethynylestradiol-induced cholestasis. Effects of ursodeoxycholic acid administrationM Arrese, M Pizarro, N Solís, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Revista Medica De Chile|February 7, 2001
[Identification of molecular defects in liver diseases. Recent advances]M Arrese
Revista Medica De Chile|April 1, 1993
[Ursodeoxycholic acid in the treatment of cholestatic liver diseases]M Arrese, L Accatino
Journal of Virology|June 1, 1996
Serine 3 is critical for phosphorylation at the N-terminal end of the nucleoprotein of influenza virus A/Victoria/3/75M Arrese, A Portela
Clinical Pharmacology and Therapeutics|March 5, 2010
Nuclear receptors, inflammation, and liver disease: insights for cholestatic and fatty liver diseasesM Arrese, S J Karpen
Revista Medica De Chile|February 11, 2000
[Molecular biology and medicine: basic concepts]S Zanlungo, A Rigotti, M Arrese
Revista Medica De Chile|February 7, 2001
[Molecular medicine: present and future]S Zanlungo, M Arrese, A Rigotti
Revista Medica De Chile|March 1, 1991
[Eosinophilic pneumonia causing severe respiratory insufficiency. Clinical case]M Arrese, J M Castellón, G Contreras
Pediatric Research|August 14, 1998
Hepatobiliary transport: molecular mechanisms of development and cholestasisM Arrese, M Ananthananarayanan, F J Suchy
Journal of Hepatology|March 1, 1997
Adaptive regulation of hepatic bile salt transport: role of bile salt hydrophobicity and microtubule-dependent vesicular pathwayM Arrese, M Pizarro, N Solís, et al.
Biochemical Pharmacology|October 12, 1995
Enhanced biliary excretion of canalicular membrane enzymes in ethynylestradiol-induced cholestasis. Effects of ursodeoxycholic acid administrationM Arrese, M Pizarro, N Solís, et al.
Pageof 5